Patent · US Active

Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy

US9075044B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 31, 2007
Grant dateJul 7, 2015
Priority date—
Expiry dateJan 14, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/57
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods are provided for inhibiting T cell mediated destruction of virally transduced, trangene containing cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.